1:42 Panel start
2:56 Panelist introductions
15:00 How to get into venture
18:51 Getting in front of VCs
23:10 How early-stage funds source deals
25:12 How VCs start companies
30:14 Accelerators and incubators
31:29 What do late-stage funds look for?
33:07 What do early-stage funds look for?
34:33 What do VCs look for in a team?
37:39 How do VCs evaluate deals?
42:06 Advice for first-time scientific founders
43:52 Value of grit
46:25 How to handle feedback
49:33 How long does it take VCs to make an investment?
51:23 Interesting trends in biotech
52:07 Opportunities in CNS / neuro
55:37 Next-gen immuno-oncology
56:25 Getting to clinical proof of concept faster and cheaper
59:15 Precision medicine -- what it really means and why it matters
1:00:02 Programming organisms, new therapeutic modalities
1:00:42 Digital therapeutics -- need for evidence
1:02:45 What makes a great team?
1:07:38 Biotech VCs vs. angel investors
1:10:17 IP for early-stage companies
1:14:11 IP for late-stage companies
1:16:04 IP attorney's thoughts on startup IP
1:17:39 Valuing platforms vs products
1:23:31 The case for the entrepreneur
1:25:47 Lean startup principles applied to biotech
We'll be organizing more events for the Bay Area biopharma community, from happy hours to panel discussions